More recently, metformin has been shown to downregulate programmed cell death receptor ligand-1 (PD-L1) in tumor cells40–42 as well as to suppress the transcription of PD-1 gene in cytotoxic T cells (CTL)43. This evidence concerns the gene CD274 and neoplasm.